Literature DB >> 1342260

Lipids and risk of coronary heart disease. The Framingham Study.

W P Castelli1, K Anderson, P W Wilson, D Levy.   

Abstract

Total cholesterol level is significantly related to risk of coronary heart disease (CHD), adjusting for other risk factors in women 50 to 79 years old and in men aged 50 to 64 years, at P < .001. Determining the levels of lipoproteins such as low-density-lipoprotein (LDL) cholesterol and high-density-lipoprotein (HDL) cholesterol improves the prediction of risk. Triglycerides are independently related in women at all ages but miss statistical significance in the multivariate studies in men. The total cholesterol-HDL cholesterol ratio is another powerful predictor at all ages in women and is the only lipid predictor independently related to CHD in men 65 to 80 years old. Inspection of the age-specific association of cholesterol with risk in men and women also reveals that the absolute rates of disease worsen with age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1342260     DOI: 10.1016/1047-2797(92)90033-m

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  127 in total

1.  Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.

Authors:  Jeffrey S Berger; Aileen P McGinn; Barbara V Howard; Lewis Kuller; Joann E Manson; Jim Otvos; J David Curb; Charles B Eaton; Robert C Kaplan; John K Lynch; Daniel M Rosenbaum; Sylvia Wassertheil-Smoller
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

2.  Development, validation and reliability of the Chrononutrition Profile - Questionnaire.

Authors:  Allison C Veronda; Kelly C Allison; Ross D Crosby; Leah A Irish
Journal:  Chronobiol Int       Date:  2019-11-25       Impact factor: 2.877

Review 3.  HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease.

Authors:  H Bryan Brewer
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 4.  The role of statins in stroke.

Authors:  Ugo Paliani; Stefano Ricci
Journal:  Intern Emerg Med       Date:  2011-05-05       Impact factor: 3.397

5.  Current serum lipoprotein levels and FMRI response to working memory in midlife.

Authors:  Mitzi M Gonzales; Takashi Tarumi; Danielle E Eagan; Hirofumi Tanaka; Fedora O Biney; Andreana P Haley
Journal:  Dement Geriatr Cogn Disord       Date:  2011-04-13       Impact factor: 2.959

6.  The rise of cholesterol testing: how much is unnecessary.

Authors:  Helen Doll; Brian Shine; Jonathan Kay; Tim James; Paul Glasziou
Journal:  Br J Gen Pract       Date:  2011-02       Impact factor: 5.386

7.  Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease.

Authors:  Joel W Hay; Kimberly L Sterling
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

8.  Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.

Authors:  David J Heal; Jane Gosden; Sharon L Smith
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

9.  A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women.

Authors:  Viktor Hamrefors; Marju Orho-Melander; Ronald M Krauss; Bo Hedblad; Peter Almgren; Göran Berglund; Olle Melander
Journal:  J Lipid Res       Date:  2009-09-22       Impact factor: 5.922

Review 10.  Fibrates for secondary prevention of cardiovascular disease and stroke.

Authors:  Deren Wang; Bian Liu; Wendan Tao; Zilong Hao; Ming Liu
Journal:  Cochrane Database Syst Rev       Date:  2015-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.